DBV Technologies (DBVT) EBITDA Margin Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -40,178.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 530.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -932.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 7,003.00 |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -500,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -500,399.00 |
| Dec 31, 2025 | -843,999.00 |
| Sep 30, 2025 | 34,954.00 |
| Jun 30, 2025 | -13,925.00 |
| Mar 31, 2025 | -255,635.00 |
| Dec 31, 2024 | -469,836.00 |
| Sep 30, 2024 | -39,053.00 |
| Jun 30, 2024 | -106,341.00 |
| Mar 31, 2024 | -86,112.00 |
| Dec 31, 2023 | -248,037.00 |
| Sep 30, 2023 | -44,204.00 |
| Jun 30, 2023 | 9,555.00 |
| Mar 31, 2023 | 21,748.00 |
| Sep 30, 2022 | -38,564.00 |
| Dec 31, 2021 | -102,862.00 |
| Sep 30, 2021 | -61,926.00 |
| Dec 31, 2018 | 94,529.00 |